Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06074601 · ClinicalTrials.gov registry record

MIRACLE of LIFE Study

A clinical trial of Preeclampsia and Preterm Birth, sponsored by Mirvie.

Active
Registry status
10,000
Enrollment target
10
Study locations

NCT06074601 is a study of Preeclampsia and Preterm Birth that is active but no longer recruiting, run by Mirvie. The registered enrollment target is 10,000 participants, above the 1,026-participant average among 39 other Preeclampsia trials with a reported enrollment target (875% higher). The trial reports 10 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06074601, a study of Preeclampsia and Preterm Birth, is active but no longer recruiting, sponsored by Mirvie.

ACTIVE NOT RECRUITING
Registry status
10,000 participants
Enrollment target
10
Study locations

Study Summary

The goal of this observational study is to develop and validate cell-free RNA-based biomarkers for predicting a variety of adverse pregnancy outcomes in a pregnant person population. The main question it aims to answer are: 1. Can cell-free RNA-based biomarkers predict which pregnant people are at greatest risk of developing adverse pregnancy outcomes (e.g., preterm birth, preeclampsia)? 2. What is the performance of such biomarkers when predicting an adverse pregnancy outcome (e.g., sensitivity, specificity, PPV, NPV, TPR)?

Conditions Studied

Preeclampsia Preterm Birth Gestational Hypertension Gestational Diabetes Mellitus in Pregnancy Preterm Labor Preterm Premature Rupture of Membrane Intrauterine Growth Restriction Small for Gestational Age at Delivery Preterm Birth Complication HELLP

Interventions

  • DIAGNOSTIC_TEST Mirvie Predictive Test for Adverse Pregnancy Outcomes

Study Locations (10)

Pennsylvania

  • Thomas Jefferson University - Philadelphia
  • University of Pittsburgh Medical Center - Pittsburgh

California

  • University of California San Diego - San Diego

Florida

  • Women's Care Florida - Orlando

Louisiana

  • Ochsner Health System - New Orleans

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

Missouri

  • Washington University School of Medicine - St Louis

Ohio

  • The Ohio State University - Columbus

Texas

  • University of Texas Medical Branch - Galveston

Trial Details

FieldValue
Enrollment Target 10,000 participants
Start Date 2021-08-01
Est. Completion 2025-12-31

Sponsor

Mirvie

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06074601

The ClinicalTrials.gov registry entry for NCT06074601 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,026-participant average among 39 other Preeclampsia trials with a reported enrollment target (875% higher). The listed sponsor is Mirvie, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Preeclampsia appearing as the primary indexed condition, and to 1 intervention - of which Mirvie Predictive Test for Adverse Pregnancy Outcomes is the first listed.

NCT06074601 reports 10 study locations spanning 9 distinct geographic areas - top geographies include Pennsylvania, California, Florida.

Frequently Asked Questions

What is clinical trial NCT06074601 about?

NCT06074601 is a clinical study titled "MIRACLE of LIFE Study". The goal of this observational study is to develop and validate cell-free RNA-based biomarkers for predicting a variety of adverse pregnancy outcomes in a pregnant person population. The main question it aims to answer are: 1. Can cell-free RNA-based biomarkers predict which pregnant people are at ...

What is the current status of trial NCT06074601?

This trial is currently active not recruiting. The enrollment target is 10,000 participants. The study started on 2021-08-01. Estimated completion is 2025-12-31.

What conditions does trial NCT06074601 study?

This clinical trial studies the following conditions: Preeclampsia, Preterm Birth, Gestational Hypertension, Gestational Diabetes Mellitus in Pregnancy, Preterm Labor.

What interventions are being tested in trial NCT06074601?

The interventions under investigation include: Mirvie Predictive Test for Adverse Pregnancy Outcomes (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06074601?

This trial is sponsored by Mirvie, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06074601 being conducted?

This trial has 10 study locations across California, Florida, Louisiana, Massachusetts, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Preeclampsia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Preeclampsia

All registered trials for this condition

Preterm Birth

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.